Published in Cancer Epidemiol Biomarkers Prev on September 01, 2005
Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. Int J Cancer (2009) 1.02
Polymorphisms in DNA damage response genes and head and neck cancer risk. Biomarkers (2010) 0.98
Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J Exp Clin Cancer Res (2009) 0.88
A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism. Acta Otorhinolaryngol Ital (2012) 0.86
Molecular alterations in the tumor suppressor gene WWOX in oral leukoplakias. Oral Oncol (2007) 0.84
Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis. PLoS One (2014) 0.80
Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A Meta-Analysis. Medicine (Baltimore) (2015) 0.79
Trends in frequency and duration of tobacco habit in relation to potentially malignant lesion: A 3 years retrospective study. J Oral Maxillofac Pathol (2013) 0.78
Association between oral leukoplakia and upper gastrointestinal cancers: a 28-year follow-up study in the Linxian General Population Trial. Oral Oncol (2014) 0.77
Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer. Indian J Med Res (2012) 0.77
GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis. PLoS One (2014) 0.76
Single nucleotide polymorphism network: a combinatorial paradigm for risk prediction. PLoS One (2013) 0.76
More on the tobacco menace in India. South Asian J Cancer (2014) 0.75
Single nucleotide polymorphisms as markers of genetic susceptibility for oral potentially malignant disorders risk: Review of evidence to date. Oral Oncol (2016) 0.75
DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects. PLoS One (2013) 0.75
Ethnic India: a genomic view, with special reference to peopling and structure. Genome Res (2003) 2.88
Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear antigen (PCNA) through Its interactions with PCNA and USP1. J Biol Chem (2010) 1.43
Mph1p promotes gross chromosomal rearrangement through partial inhibition of homologous recombination. J Cell Biol (2008) 1.28
Predisposition to cancer caused by genetic and functional defects of mammalian Atad5. PLoS Genet (2011) 1.18
Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer (2007) 1.03
SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit. J Pathol (2009) 1.03
Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med (2008) 0.97
Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer. Mol Carcinog (2009) 0.96
Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers. Int J Cancer (2004) 0.94
HnRNP E2 is downregulated in human oral cancer cells and the overexpression of hnRNP E2 induces apoptosis. Mol Carcinog (2007) 0.93
Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett (2003) 0.93
Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: Correlation with progression and prognosis. Int J Cancer (2008) 0.93
Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and Autosomal GSTP1 locus. Cancer (2007) 0.93
Pharmacogenomics of anti-TB drugs-related hepatotoxicity. Pharmacogenomics (2008) 0.92
Suppression of gross chromosomal rearrangements by a new alternative replication factor C complex. Biochem Biophys Res Commun (2007) 0.92
Bladder cancer documentation of causes: multilingual questionnaire, 'bladder cancer doc'. Front Biosci (Elite Ed) (2012) 0.90
Genetic variations at microRNA and processing genes and risk of oral cancer. Tumour Biol (2013) 0.89
Automated oral cancer identification using histopathological images: a hybrid feature extraction paradigm. Micron (2011) 0.88
Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression. J Clin Pathol (2010) 0.87
Risk assessment of p53 genotypes and haplotypes in tobacco-associated leukoplakia and oral cancer patients from eastern Idia. Int J Cancer (2005) 0.87
Differential alterations of the genes in the CDKN2A-CCND1-CDK4-RB1 pathway are associated with the development of head and neck squamous cell carcinoma in Indian patients. J Cancer Res Clin Oncol (2003) 0.86
Predisposition of antituberculosis drug induced hepatotoxicity by cytochrome P450 2E1 genotype and haplotype in pediatric patients. J Gastroenterol Hepatol (2006) 0.86
ApoTome to visualize E-cadherin and p63 expression in oral pre-cancer. Biotechnol J (2011) 0.85
Comprehensive SNP scan of DNA repair and DNA damage response genes reveal multiple susceptibility loci conferring risk to tobacco associated leukoplakia and oral cancer. PLoS One (2013) 0.84
Epithelio-mesenchymal transitional attributes in oral sub-mucous fibrosis. Exp Mol Pathol (2013) 0.80
CYP1AI and CYP2E1 gene polymorphisms may increase susceptibility to oral submucous fibrosis among betel quid chewers of eastern India. Gene (2012) 0.79
Quantitative dimensions of histopathological attributes and status of GSTM1-GSTT1 in oral submucous fibrosis. Tissue Cell (2008) 0.77
Computer vision approach to morphometric feature analysis of basal cell nuclei for evaluating malignant potentiality of oral submucous fibrosis. J Med Syst (2010) 0.77
Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer. Indian J Med Res (2012) 0.77
D-loop somatic mutations and ∼5 kb "common" deletion in mitochondrial DNA: important molecular markers to distinguish oral precancer and cancer. Tumour Biol (2014) 0.76
Single nucleotide polymorphism network: a combinatorial paradigm for risk prediction. PLoS One (2013) 0.76
Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples. J Oral Pathol Med (2008) 0.76
Genetic analysis of familial spontaneous pneumothorax in an Indian family. Lung (2015) 0.75
Loss of heterozygosity at APC and MCC genes of oral cancer and leukoplakia tissues from Indian tobacco chewers. J Oral Pathol Med (2003) 0.75
Automated classification of cells in sub-epithelial connective tissue of oral sub-mucous fibrosis-an SVM based approach. Comput Biol Med (2009) 0.75
Structural markers for normal oral mucosa and oral sub-mucous fibrosis. Micron (2009) 0.75
Performance analysis of different wavelet feature vectors in quantification of oral precancerous condition. Oral Oncol (2006) 0.75
Textural characterization of histopathological images for oral sub-mucous fibrosis detection. Tissue Cell (2011) 0.75
Differential haplotype amplification leads to misgenotyping of heterozygote as homozygote when using single nucleotide mismatch primer. Electrophoresis (2012) 0.75